Specifically, significant decreases in expression of HMOX1 (−50-fold, p = 0.03) and aldolase (ALDOA; −500-fold, p = 0.01) were observed in CD49fhiCD24hi cancer cells compared with benign cell counterparts. The gene discussed is ALDOA; the disease is cancer.